References
- Nathan C. Nph and immunity: Challenges and opportunities. Nat Rev Immunol 2006; 6: 173–182
- Gordon S. Alternative activation of MΦ. Nat Rev Immunol 2003; 3: 23–35
- Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M. The chemokine system in diverse forms of MΦ activation and polarization. Trends Immunol 2004; 25: 677–686
- Stout RD, Jiang C, Matta B, Tietzel I, Watkins SK, Suttles J. MΦ sequentially change their functional phenotype in response to changes in microenvironmental influences. J Immunol 2005; 175: 342–349
- Jersmann HP, Ross KA, Vivers S, Brown SB, Haslett C, Dransfield I. Phagocytosis of apo cells by human MΦ: Analysis by multiparameter flow cytometry. Cytometry A 2003; 51: 7–15
- Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH. Human IL-23-producing type 1 MΦ promote but IL-10-producing type 2 MΦ subvert immunity to (myco)bacteria. Proc Natl Acad Sci USA 2004; 101: 4560–4565
- Xu W, Roos A, Schlagwein N, Woltman AM, Daha MR, van Kooten C. IL-10-producing MΦ preferentially clear early apo cells. Blood 2006; 107: 4930–4937